Lilly Teva: Which Pharmaceutical Stock Shines in 2026?
As 2026 unfolds, investors face a clear choice between Lilly's growth engine in big markets and Teva's value-forward ...
Are you in your 20s and wondering if a financial advisor is right for you? Learn who should consider seeking professional financial help.
26,867 articlesAs 2026 unfolds, investors face a clear choice between Lilly's growth engine in big markets and Teva's value-forward ...
In a move with broad market implications, Japan's finance ministry asks a major pension fund to tilt more toward dome...
A notable stake by Starboard Value in Fluor hints at renewed confidence in the industrial cycle. This article explain...
As Berkshire's new investment captain, Greg Abel faces a pivotal test: can his Q2 moves in Alphabet, Mitsubishi, Maru...
As mega-cap tech pours capital into AI, investors seek signs of durable returns. This piece analyzes which firms stan...
A senior Iranian official publicly mocks Trump's appeal to help reopen the Hormuz Strait as tensions intensify, with ...
Iranian strikes have sharply reduced Qatar's LNG output, cutting roughly 17% of capacity and threatening global suppl...
A federal jury in San Francisco ruled that Elon Musk misled Twitter investors ahead of the 2022 buyout, setting up a ...
Iran publicly spurns ceasefire talks amid renewed attacks, while the White House insists talks continue. The flare-up...
In a market of flashing headlines, a few steady names stand out for reliable income. This guide breaks down three blu...
A landmark, independent study finds racial disparities in AI-driven hiring tools used by major employers, affecting B...
A looming 2027 COLA could lift benefits by billions, but inflation momentum and policy hurdles threaten social securi...